Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Magnesium oxide 160mg capsules
0101010I0AAACAC
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | 424 |
|
Magnesium oxide 500mg capsules
0101010I0AAAYAY
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | 273 |
|
Oromag 160 capsules
0101010I0BEAAAC
|
Oromag 160 | Magnesium oxide | Gastro-Intestinal System | 204 |
|
Magnesium oxide 100mg capsules
0101010I0AAABAB
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | 171 |
|
Magnesium oxide 100mg tablets
0101010I0AAAEAE
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | 154 |
|
Magnesium oxide 160mg tablets
0101010I0AAALAL
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | 122 |
|
Magdose 160mg capsules
0101010I0BFADAC
|
Magdose | Magnesium oxide | Gastro-Intestinal System | 56 |
|
Magnesium oxide 400mg tablets
0101010I0AABIBI
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | 46 |
|
Magdose 500mg capsules
0101010I0BFAEAY
|
Magdose | Magnesium oxide | Gastro-Intestinal System | 24 |
|
Magdose 100mg tablets
0101010I0BFAAAE
|
Magdose | Magnesium oxide | Gastro-Intestinal System | 21 |
|
Magdose 100mg capsules
0101010I0BFABAB
|
Magdose | Magnesium oxide | Gastro-Intestinal System | 13 |
|
Mag-100 capsules
0101010I0BJAAAB
|
Mag-100 | Magnesium oxide | Gastro-Intestinal System | 1 |
|
Mag-Ox 400 tablets
0101010I0BCAABI
|
Mag-Ox | Magnesium oxide | Gastro-Intestinal System | 1 |
|
Magnesium oxide 375mg tablets
0101010I0AABRBR
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | 1 |
|
MagnEss 160mg capsules
0101010I0BHABAC
|
MagnEss | Magnesium oxide | Gastro-Intestinal System | 1 |
|
MagnEss 500mg capsules
0101010I0BHACAY
|
MagnEss | Magnesium oxide | Gastro-Intestinal System | 1 |
|
AdMag 100mg tablets
0101010I0BMACAE
|
AdMag | Magnesium oxide | Gastro-Intestinal System | No data available |
|
AdMag 160mg tablets
0101010I0BMABAL
|
AdMag | Magnesium oxide | Gastro-Intestinal System | No data available |
|
AdMag 400mg tablets
0101010I0BMAABI
|
AdMag | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Mag-160 capsules
0101010I0BKAAAC
|
Mag-160 | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Mag-500 capsules
0101010I0BLAAAY
|
Mag-500 | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magdose 160mg tablets
0101010I0BFACAL
|
Magdose | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magdose 400mg tablets
0101010I0BFAFBI
|
Magdose | Magnesium oxide | Gastro-Intestinal System | No data available |
|
MagnaOx 160mg capsules
0101010I0BIAAAC
|
MagnaOx | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magnesium oxide 10mg capsules
0101010I0AAAJAJ
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.